Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Sevikar HCT®:Daiichi Sankyo (Schweiz) AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
C09DX03 - Olmesartan Medoxomil, Amlodipine and HydrochlorothiazideATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
C09 - Agents Acting on The Renin-Angiotensin System

The DDDs are based on the treatment of mild-moderate hypertension.
See comments to C02L concerning the principles for assignment of DDDs for combined preparations.

C09D - Angiotensin Ii Receptor Blockers (Arbs), Combinations

Combinations with statins are classified in C10BX.

C09DX - Angiotensin Ii Receptor Blockers (Arbs), Other Combinations
C09DX03 - Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
2021 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home